FOXA1 and osteosarcoma: Research had shown that NR2F1-AS1 upregulated FOXA1 through the adsorption of miR-483-3p, thus increasing the malignant degree of osteosarcoma and suggested it might be a potential therapeutic target for osteosarcoma.[29]